Piramal Pharma Solutions vs Samsung Biologics: CDMO Comparison
Side-by-side comparison of Piramal Pharma Solutions and Samsung Biologics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Piramal Pharma Solutions has more FDA inspections on record (5 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Piramal Pharma Solutions holds 1 active EMA GMP certificates; Samsung Biologics does not appear in EudraGMDP.
- Piramal Pharma Solutions maintains 12 MHRA / UK GMP certificates; Samsung Biologics does not.
- Composite Signal Score: Piramal Pharma Solutions 84/100 vs Samsung Biologics 68/100 — a 15-point gap reflecting the combined quality, capacity and financial signal.
On a 13-modality CDMO landscape, both Piramal Pharma Solutions and Samsung Biologics qualify as ADC manufacturers; Piramal Pharma Solutions carries the higher composite Signal Score for ADC programs in this comparison.
What to evaluate for ADC programs
Both Piramal Pharma Solutions and Samsung Biologics qualify as ADC CDMOs. When choosing between them for ADC programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
HPAPI containment
Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work.
Linker-payload chemistry on file
Match the CDMO's payload + linker experience to your program. MMAE / vc-MMAE is the most common; PBDs, calicheamicin, Dxd-class topoI inhibitors, and TLR agonists each carry distinct handling and analytical demands.
Commercial bioconjugation track record
Has the CDMO conjugated a commercially-approved ADC? Track record on Polivy, Padcev, Trodelvy, Enhertu, Tivdak, Elahere, Adcetris, Mylotarg, Besponsa, Lumoxiti, Blenrep, etc. is a strong qualifying signal.
Integrated DS + DP
Bioconjugation produces ADC drug substance; you'll also need sterile fill-finish for drug product. Confirm whether the CDMO covers both or partners — both routes work, but integrated is faster on transfer.
Frequently asked: Piramal Pharma Solutions vs Samsung Biologics
Which has the stronger FDA inspection record, Piramal Pharma Solutions or Samsung Biologics?
Both Piramal Pharma Solutions and Samsung Biologics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Piramal Pharma Solutions has 5 FDA inspections on record; Samsung Biologics has 0.
How do Piramal Pharma Solutions and Samsung Biologics compare on European GMP coverage?
Piramal Pharma Solutions holds 1 active EMA GMP certificate and 12 MHRA / UK certificates. Samsung Biologics holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for ADC manufacturing — Piramal Pharma Solutions or Samsung Biologics?
Both Piramal Pharma Solutions and Samsung Biologics are tagged as ADC CDMOs in our directory, so both are credible options for ADC programs. The most important differentiator for ADC selection is typically hpapi containment: Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Piramal Pharma Solutions carries a Signal Score of 84/100 and Samsung Biologics carries 68/100 — a meaningful lead for Piramal Pharma Solutions. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →